{
    "organizations": [],
    "uuid": "e3c69c3ddc50b2bf24874fd181cf03a8518f9eb4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indivior-says-enters-into-license/brief-indivior-says-enters-into-license-agreement-for-c4x-discoverys-ox1-antagonist-program-idUSFWN1RB03A",
    "ord_in_thread": 0,
    "title": "‍Indivior Says Enters Into License Agreement For C4x Discovery's OX1 Antagonist Program​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Indivior Plc:\n* ‍INDIVIOR ENTERS INTO AN EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR C4X DISCOVERY’S OREXIN-1 (OX1) ANTAGONIST PROGRAM​\n* ‍INDIVIOR UK LIMITED AND C4X DISCOVERY HOLDINGS PLC ENTERED INTO A LICENSE AGREEMENT​\n* INDIVIOR - ‍UNDER AGREEMENT, INDIVIOR UK OBTAINED EXCLUSIVE GLOBAL RIGHTS TO DEVELOP AND COMMERCIALIZE C4X’S ORAL OREXIN-1 RECEPTOR ANTAGONIST PROGRAM​\n* INDIVIOR - ‍INDIVIOR UK WILL MAKE AN UPFRONT PAYMENT TO C4X OF $10 MILLION WITH POTENTIAL MILESTONE PAYMENTS TO C4X THAT COULD TOTAL $284 MILLION OVER TIME​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-03-29T15:11:00.000+03:00",
    "crawled": "2018-03-30T13:26:23.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "indivior",
        "plc",
        "enters",
        "exclusive",
        "global",
        "license",
        "agreement",
        "c4x",
        "discovery",
        "ox1",
        "antagonist",
        "uk",
        "limited",
        "c4x",
        "discovery",
        "holding",
        "plc",
        "entered",
        "license",
        "indivior",
        "agreement",
        "indivior",
        "uk",
        "obtained",
        "exclusive",
        "global",
        "right",
        "develop",
        "commercialize",
        "c4x",
        "oral",
        "receptor",
        "antagonist",
        "indivior",
        "uk",
        "make",
        "upfront",
        "payment",
        "c4x",
        "million",
        "potential",
        "milestone",
        "payment",
        "c4x",
        "could",
        "total",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}